1-2 of 2
Leanthe Braunert, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Claudia Nehring, Cornelia Becker, MD, Leanthe Braunert, MD, Sabine Leiblein, Jeanett Edelmann, Georg Franke, MD, Wolfram Poenisch, Thoralf Lange, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2011) 118 (21): 3065.
https://doi.org/10.1182/blood.V118.21.3065.3065
Published: 2011
Journal Articles

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Leanthe Braunert, MD, Ginna G. Laport, MD, Thomas Chauncey, MD, Christopher Bredeson, Richard T Maziarz, MD, Michael A. Pulsipher, MD, Edward Agura, MD, Michael T. Maris, MD, Lars Vindelov, MD, Firoozeh Sahebi, M.D., Peter McSweeney, Benedetto Bruno, MD, Amelia Langston, MD, Rainer F. Storb, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 2364.
https://doi.org/10.1182/blood.V116.21.2364.2364
Published: 2010